Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

Part of paid clinical trials in Charlotte, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT04577599
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
40 Years - 54 Years
Healthy Volunteers
Accepted

Interventions

  • Mobile Low-dose Computed Tomography (LDCT) Screening — OTHER
    Low Dose CT Scan of the Chest

Study Details

Low-dose CT Screening has been shown in two large trials in the United States (NLST) and Europe (NELSON) to increase overall survival in subjects 55 years of age and older with a strong smoking history. Unfortunately, in both North Carolina (NC) and South Carolina (SC), subjects are found to have the above referenced smoking history prior to reaching the minimum age in these studies. This study is aimed at decreasing the minimum age of screening in a high-risk population.

Key Dates

Start date
Jan 7, 2021
Status verified
Jan 2026
Primary completion
Oct 31, 2028
Completion
Oct 31, 2028

Study Design

Enrollment
1,160 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING

Arms

  • Other: Single Arm
    Mobile Low-dose Computed Tomography (LDCT) Screening

Primary Outcome Measure

Lung cancer diagnosis rate in individuals 40-54 years of age at their first screening (T0) with mobile low-dose CT. [ Time Frame: 1 day ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Levine Cancer InstituteCharlotteNorth Carolina28204
Darcy Doege, RN
[email protected]
913-424-6431
Daniel Carrizosa, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Charlotte, NC

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Levine Cancer Institute· Charlotte, NC

Related Studies